Women's Health News

RSS

Olaparib shows promising results against inherited forms of breast and ovarian cancer

Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising results against inherited forms of breast and ovarian cancer in two small clinical trials led by scientists at the Breakthrough Breast Cancer Research Unit at King's College London.

8 Jul 2010

Invision Sally Jobe introduces SBU technology for early detection of breast cancer

Invision Sally Jobe is among the first diagnostic imaging networks in the nation to offer a new breast ultrasound technology for the early detection of cancer. Screening Breast Ultrasound is a highly effective technology developed to complement mammography in women with radiologically dense breasts and other risk factors.

7 Jul 2010

Social, psychological factors rather than biological changes influence women's sexual behaviour during menopause

New research from the University of Sheffield has found that social and psychological factors have the biggest influence upon women's sexual behaviour during the menopause, rather than biological changes such as declining hormone levels.

7 Jul 2010

Study shows gene-environment interaction in congenital heart disease

A pregnant mother's diet may be able to interact with the genes her unborn child inherits and influence the type or severity of birth defect according to research funded by the Wellcome Trust and the British Heart Foundation. The study, published in the journal Human Molecular Genetics, suggests that mothers who eat a high fat diet before and through pregnancy could be inadvertently putting the health of their offspring at risk.

7 Jul 2010

Genentech submits BLA for trastuzumab-DM1 in advanced HER2-positive breast cancer

Genentech, a member of the Roche Group, today announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trastuzumab-DM1 (T-DM1) in people with advanced HER2-positive breast cancer who have previously received multiple HER2-targeted medicines and chemotherapies.

7 Jul 2010

QIAGEN receives CE conformity marking for careHPV Test

QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.

From QIAGEN Manchester Limited 7 Jul 2010

KHN column – Insuring your health: Should patients get contraceptives from health plans at no cost?

"The average American woman who wants two children spends roughly five years trying to get pregnant or being pregnant. She spends a much longer time - 30 years, on average - trying to avoid pregnancy, often at no small expense. That may soon change, at least the expense part" (7/6).

7 Jul 2010

Washington Post examines birth simulator for health worker training in developing world

A new device which simulates childbirth on a real woman could help train health workers to deliver babies and deal with complications, according to the Washington Post, which adds that the $100 low-tech "frontpack" is called "'MamaNatalie,' a name that plays on 'natalis,' which means 'pertaining to birth' in Latin."

7 Jul 2010

International conference focuses on HPV's impact on women

Scientists, clinicians and public health leaders from around the world are gathered in Montreal this week for the 26th International Papillomavirus Conference where they hope to generate awareness about human papillomavirus, Canwest News Service/Gazette reports (Martin/McCallum, 7/4).

7 Jul 2010

Hope for ovarian cancer patients not responding to conventional chemotherapy

Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy.

6 Jul 2010

Novel molecular pathway that regulates invasive growth, metastasis in ER-positive breast cancer discovered

A multi-disciplinary team of international researchers from Ghent University in Belgium, National Human Genome Research Institute (NHGRI) in the US, Imperial College London in the United Kingdom, and INSERM in France have uncovered a novel molecular pathway that regulates invasive growth and metastasis in estrogen receptor-positive breast cancer.

6 Jul 2010

New blood test eliminates need for surgical lung biopsy for LAM diagnosis

Researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis (LAM) in some patients, eliminating the need for surgical lung biopsy to make a diagnosis.

6 Jul 2010

Novel therapy slows tumor growth in 85% of advanced breast cancer patients: Study

A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study, researchers report in the July 6 issue of The Lancet.

6 Jul 2010

Mass vaccination has reduced the incidence of genital warts by 60%: Report

Genital warts, commonly caused by human papillomavirus (HPV) are on the decline after routine vaccination of Australian women with a vaccine against HPV. The sexual partners of these women are also beneficiaries of the vaccine.

5 Jul 2010

Web sites that promote anorexia raise concern

For women with low self-esteem, poor body image and a certain genetic predisposition towards an eating disorder, the messages promoted on pro-eating disorder web sites can be similar to someone considering suicide finding a loaded gun on her pillow.

3 Jul 2010

Study finds EPB41L3 'protector gene' inactivated in 65% of ovarian cancers

A new gene that normally protects against ovarian cancer is switched-off in two-thirds of cases of the disease, reveals a study published in the journal Neoplasia today.

3 Jul 2010

Women have longer life expectancy, but with prevalence of disability in old age

Although women have a longer life expectancy, they experience a much greater prevalence of disability in old age than men do. This is the main conclusion of the study published in the latest issue of the Journal of Women's Health.

3 Jul 2010

Metabolon unveils novel approach to identify patients at preterm delivery risk

Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery", in The Journal of Maternal-Fetal and Neonatal Medicine.

3 Jul 2010

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software. Using the arc-based Elekta VMAT delivery method, Monaco displays how the radiation dose should be applied — its distribution and strength on the target. The result is a therapy that not only is rapid, but also fine-tuned to treat cancer and avoid healthy tissues.

From Elekta 3 Jul 2010

U.N. to formally establish new 'gender entity'

The U.N. General Assembly will move to formally adopt a new "gender entity" on Friday called "U.N. Women" that will fold the U.N.'s four existing women's entities - UNIFEM, the Office of the Special Adviser on Gender Issues, the U.N. Division for the Advancement of Women and INSTRAW - into one, Inter Press Service reports.

3 Jul 2010

Women's Health News

Olaparib shows promising results against inherited forms of breast and ovarian cancer

Invision Sally Jobe introduces SBU technology for early detection of breast cancer

Social, psychological factors rather than biological changes influence women's sexual behaviour during menopause

Study shows gene-environment interaction in congenital heart disease

Genentech submits BLA for trastuzumab-DM1 in advanced HER2-positive breast cancer

QIAGEN receives CE conformity marking for careHPV Test

KHN column – Insuring your health: Should patients get contraceptives from health plans at no cost?

Washington Post examines birth simulator for health worker training in developing world

International conference focuses on HPV's impact on women

Hope for ovarian cancer patients not responding to conventional chemotherapy

Novel molecular pathway that regulates invasive growth, metastasis in ER-positive breast cancer discovered

New blood test eliminates need for surgical lung biopsy for LAM diagnosis

Novel therapy slows tumor growth in 85% of advanced breast cancer patients: Study

Mass vaccination has reduced the incidence of genital warts by 60%: Report

Web sites that promote anorexia raise concern

Study finds EPB41L3 'protector gene' inactivated in 65% of ovarian cancers

Women have longer life expectancy, but with prevalence of disability in old age

Metabolon unveils novel approach to identify patients at preterm delivery risk

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

U.N. to formally establish new 'gender entity'

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News